Skip to main content
Erschienen in:

01.06.2019 | News item

New dose recommendations for dabigatran etexilate in NZ

Erschienen in: Reactions Weekly | Ausgabe 1/2019

Einloggen, um Zugang zu erhalten

Excerpt

New reduced dose recommendations will soon apply for use of dabigatran etexilate (Pradaxa) for treatment and prevention of DVT and PE,1 says Medsafe in New Zealand (NZ). …
Fußnoten
1
DVT = deep vein thrombosis; PE = pulmonary embolism
 
2
SPAF = prevention of stroke, systemic embolism and reduction of vascular death in patients with atrial fibrillation.
 
Metadaten
Titel
New dose recommendations for dabigatran etexilate in NZ
Publikationsdatum
01.06.2019
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2019
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-019-63549-6